A novel clinical trial aims to help more patients with aggressive blood cancers access transplants—without the delays or limitations of traditional donor matching.
Cell biologist Bruce Edgar, recognized for his research on cell growth and proliferation, was elected to the prestigious National Academy of Sciences for his pioneering work and contributions to science.
Huntsman Cancer Foundation Chairman and Chief Executive Officer Peter Huntsman announced the appointment of Michael Delzotti as president and chief operating officer of the organization following a national search.
Huntsman Cancer Institute, the Mountain West’s only National Cancer Institute-designated Comprehensive Cancer Center, celebrated the ceremonial groundbreaking for its second major location in one of the country’s fastest growing counties.
Over 7% of Medicare patients travel across state borders for cancer care, though the percentage nearly doubles for rural patients. Tracy Onega says this has major impacts on telehealth policy.
Their innovative research, supported by federal funding, shape the future of cancer care, from using digital communications to better access genetic services to increasing medicine’s effectiveness while lessening side effects.
A novel oral combination drug therapy evaluated at Huntsman Cancer Institute could treat and prevent melanoma spreading to the brain. Brain metastasis is the main cause of death from melanoma.
New findings highlight the positive impact of personalized exercise programs for lung cancer patients undergoing surgery and how they directly enhance patient outcomes, particularly in women.
Genomic analyses funded by the National Cancer Institute show that ovarian cancer mutations are nearly identical across populations, yet some differences emerged. This information may be relevant for treatment decisions.
These awards advance cancer research, support scientists, and establish a training program for students. The funding underscores a commitment to future cancer investigators and better patient outcomes.
Three executive leaders describe how they see Huntsman Cancer Institute advancing cancer care and research in 2025 and beyond, including increasing cancer care access for all.
Deanna Kepka, PhD, MPH, and the Global Oncology Initiative are revolutionizing cancer care through innovative HPV-related prevention and international partnerships, addressing global disparities in care.
Anna Parks, MD, was awarded the American Society of Hematology Junior Faculty Scholar Award, which supports promising early career hematologists committed to advancing the field through innovative research.
Five-year federally funded program aims to improve cancer care for rural and frontier residents in the Mountain West, bringing the latest in cancer care by providing access to clinical trials.
Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.
